UNIFI Long-Term Extension Shows Safety, Efficacy of Ustekinu

Results confirmed the long-term efficacy of ustekinumab maintenance in patients with ulcerative colitis, demonstrating consistent rates of symptomatic remission and endoscopic improvement with no new safety signals.

Related Keywords

Waqqas Afif , Media Center , Drug Administration , Mcgill University , Inflammatory Bowel Disease Questionnaire , Ulcerative Colitis Through , Final Results , Severely Active Ulcerative , Maintenance Ustekinumab , Ulcerative Colitis , Bustekinumab , Unifi , Interleukin 23 , Il 23 , Il 12 , Inflammatory Bowel Disease , Ibd , Crohn X27s Disease , Stelara ,